What is the safe loading dose for a patient who is refusing to be weighed, with a last known weight of 179lbs?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Safe Loading Dose Without Current Weight

Use the last known weight of 179 lbs (81 kg) to calculate the loading dose, as this represents the most recent objective measurement available and is the standard of care when current weight cannot be obtained. 1

General Principles for Loading Dose Calculation

When a patient refuses to be weighed, the most appropriate approach depends on the specific medication being administered:

Weight-Based Dosing Strategy

  • For most medications requiring loading doses, use the most recent documented weight (in this case, 179 lbs or 81 kg) as the basis for calculation, as this provides the most accurate available data for dosing. 1

  • The timing of the last weight measurement matters less than having an objective measurement, particularly when the alternative is estimation or guessing, which introduces greater error and safety risk. 1

Medication-Specific Considerations

For anticoagulants (if applicable):

  • Unfractionated heparin (UFH): Use weight-based dosing of 60 U/kg loading dose with a suggested maximum of 4000 U, followed by 12 U/kg/h infusion with a maximum of 900 U/h. For a patient weighing 81 kg, this would be approximately 4000 U loading dose (at the cap). 2

  • Low molecular weight heparin (LMWH): Calculate based on actual body weight - enoxaparin 1 mg/kg subcutaneously. For 81 kg, this would be 81 mg. 2

  • GP IIb/IIIa inhibitors:

    • Eptifibatide: 180 mcg/kg loading dose (approximately 14,580 mcg or 14.6 mg for 81 kg). 2
    • Tirofiban: 12 mcg/kg loading dose (approximately 972 mcg for 81 kg). 2

For antiplatelet agents (if applicable):

  • Aspirin: Loading dose of 162-325 mg (non-weight-based), which should be chewed for faster onset. 2

  • Clopidogrel: Loading dose of 300-600 mg (non-weight-based). 2

  • Prasugrel: Loading dose of 60 mg (non-weight-based), though contraindicated if weight <60 kg. At 81 kg, this patient is well above the weight threshold. 2

  • Ticagrelor: Loading dose of 180 mg (non-weight-based). 2

Critical Safety Considerations

  • For drugs with narrow therapeutic indices or high bleeding risk, using the last documented weight is safer than estimation, as it provides an objective reference point for dose calculation. 1

  • Document clearly in the medical record that the dose was calculated using the last known weight from [DATE] due to patient refusal to be weighed, and note the specific weight used (179 lbs/81 kg). 1

  • Monitor closely for adverse effects, particularly if there is reason to believe significant weight change has occurred since the last measurement. 2

  • For obese patients (BMI >30), some medications may require adjusted body weight rather than actual body weight for loading doses, though at 179 lbs this is unlikely to be a concern unless the patient is very short. 3, 4

When Last Weight May Be Inadequate

  • If the last weight is >6-12 months old or if there are obvious clinical signs of significant weight change (edema, cachexia, pregnancy), consider using clinical judgment to adjust the dose conservatively or use ideal body weight calculations as a safer alternative. 3

  • For drugs distributed primarily in lean tissue (aminoglycosides, neuromuscular blockers), ideal body weight may be more appropriate than actual body weight even when actual weight is known. 3

References

Research

Patient Weight Should Be Included on All Medication Prescriptions.

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG, 2023

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Clinical pharmacokinetics of drugs in obesity. An update.

Clinical pharmacokinetics, 1993

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.